1. Home
  2. FDMT vs BXC Comparison

FDMT vs BXC Comparison

Compare FDMT & BXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 4D Molecular Therapeutics Inc.

FDMT

4D Molecular Therapeutics Inc.

N/A

Current Price

$10.21

Market Cap

695.3M

Sector

Health Care

ML Signal

N/A

Logo Bluelinx Holdings Inc.

BXC

Bluelinx Holdings Inc.

N/A

Current Price

$55.91

Market Cap

706.5M

ML Signal

N/A

Company Overview

Basic Information
Metric
FDMT
BXC
Founded
2013
2004
Country
United States
United States
Employees
N/A
1700
Industry
Biotechnology: Pharmaceutical Preparations
Wholesale Distributors
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
695.3M
706.5M
IPO Year
2019
2004

Fundamental Metrics

Financial Performance
Metric
FDMT
BXC
Price
$10.21
$55.91
Analyst Decision
Strong Buy
Buy
Analyst Count
12
4
Target Price
$28.09
★ $85.00
AVG Volume (30 Days)
★ 855.5K
135.7K
Earning Date
11-12-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 18.79
N/A
EPS
N/A
★ 0.54
Revenue
★ $85,209,000.00
N/A
Revenue This Year
N/A
$4.83
Revenue Next Year
$20.79
$2.92
P/E Ratio
★ N/A
$105.76
Revenue Growth
★ 230194.60
N/A
52 Week Low
$6.96
$44.78
52 Week High
$16.93
$93.80

Technical Indicators

Market Signals
Indicator
FDMT
BXC
Relative Strength Index (RSI) 37.51 29.38
Support Level $8.43 $47.84
Resistance Level $10.61 $62.94
Average True Range (ATR) 0.85 5.00
MACD -0.15 -1.10
Stochastic Oscillator 1.07 2.90

Price Performance

Historical Comparison
FDMT
BXC

About FDMT 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).

About BXC Bluelinx Holdings Inc.

BlueLinx Holdings Inc is engaged in the wholesale distribution of residential and commercial building products. Its business products are split into two categories: Structural products include items such as lumber, plywood, oriented strand board, rebar, and remesh, and Specialty products include items such as engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products. The company's operations are carried out throughout the United States.

Share on Social Networks: